17:19 EST Aligos Therapeutics (ALGS) files $400M mixed securities shelf
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGS:
- Aligos Therapeutics reports Q3 EPS ($3.07), consensus ($2.16)
- Aligos announces FDA cleared IND for Phase 1 DDI study of ALG-000184
- JMP Securities healthcare analysts hold an analyst/industry conference call
- Aligos Therapeutics announces inducement grants under Nasdaq listing rule
- Aligos Therapeutics appoints David Perry as VP, business development